Thursday, March 14, 2013

• Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?at Seeking Alpha (Thu, Mar 14)

Wednesday, March 13, 2013

• AVEO Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 09:00 AMat Seeking Alpha (Wed, Mar 13)

Tuesday, March 12, 2013

• Best And Worst FDA Drug Approval Stocks of 2013at TheStreet (Tue, Mar 12)

Monday, March 11, 2013

• AVEO PHARMACEUTICALS INC Files SEC form 10-K, Annual ReportEDGAR Online (Mon, Mar 11)

Wednesday, March 6, 2013

• Panel to Review AVEO/ALPMY's DrugZacks (Wed, Mar 6)
• AVEO Oncology to Present at the Barclays Global Healthcare ConferenceBusiness Wire (Wed, Mar 6)

Wednesday, February 27, 2013

• AVEO to meet with FDA about tivozanibat bizjournals.com (Wed, Feb 27)
• AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Wed, Feb 27)
• Aveo Pharmaceuticals' NDA for tivozanib to be reviewed by FDA on May 2at theflyonthewall.com (Wed, Feb 27)
• AVEO and Astellas Announce FDA Advisory Committee To Review Tivozanib for the Treatment of Advanced Renal Cell CarcinomaBusiness Wire (Wed, Feb 27)

Thursday, February 21, 2013

• Astellas Needs To Pick A Model To Prosperat Seeking Alpha (Thu, Feb 21)
• U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year PreviousMarketwired (Thu, Feb 21)

Wednesday, February 20, 2013

• AVEO Oncology to Present at the 2013 RBC Capital Markets’ Healthcare ConferenceBusiness Wire (Wed, Feb 20)

Thursday, February 14, 2013

• Anheuser-Busch InBev Expected to Rally and 4 Stock Analyses Making Roundsat Wall St. Cheat Sheet (Thu, Feb 14)
• Tracking Seth Klarman's Baupost Group Holdings - Q4 2012 Updateat Seeking Alpha (Thu, Feb 14)

Wednesday, February 13, 2013

• AVEO: Final Overall Survival Results From The TIVO­1 Studyat Seeking Alpha (Wed, Feb 13)
• Why Shares of AVEO Hit the Brakes Todayat Motley Fool (Wed, Feb 13)
• Data on AVEO/ALPMY's TivozanibZacks (Wed, Feb 13)
• AVEO Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Feb 13)
• Aveo stock plunges on disappointing kidney cancer study dataat bizjournals.com (Wed, Feb 13)
• Why Aveo Pharmaceuticals Shares Plungedat Motley Fool (Wed, Feb 13)
• AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Wed, Feb 13)
• AVEO Pharmaceuticals Earnings: Here’s Why Investors are Not Happy Nowat Wall St. Cheat Sheet (Wed, Feb 13)
• Aveo Pharma: 'Crossover' Ate My Kidney Cancer Drug Survival Benefitat TheStreet (Wed, Feb 13)
• AVEO Reports 2012 Financial Results and Highlights Recent AccomplishmentsBusiness Wire (Wed, Feb 13)

Add AVEO News to My Yahoo!